Table 2.
Univariate analysis of risk factors for complications and fistulas after pancreaticoduodenectomy
| Complication < IIIb | Complication IIIb ≤ | p< | No Grade B or C fistula | Grade B or C fistula | p< | |
|---|---|---|---|---|---|---|
| CT data | ||||||
| AVAT [cm2] | 123 | 157 | 0.06 | 120 | 180.1 | 0.01 |
| AMPSO [cm2] | 20.3 | 18.9 | 0.12 | 20.3 | 18.5 | 0.24 |
| AMSPI [cm2] | 55.8 | 52.7 | 0.37 | 56.2 | 52.0 | 0.05 |
| AMVEN [cm2] | 55.7 | 58.3 | 0.73 | 56.5 | 57.2 | 0.64 |
| AMTOT [cm2] | 130 | 130.0 | 0.83 | 131 | 127 | 0.32 |
| MA [HU] | 40.7 | 33.0 | 0.01 | 40.3 | 33.1 | 0.01 |
| SMI [cm2/m2] | 44.5 | 44.9 | 0.77 | 44.9 | 43.4 | 0.30 |
| DPP [mm] | 17.3 | 19.3 | 0.14 | 17.5 | 18.7 | 0.55 |
| DPD [mm] | 3.00 | 2.40 | 0.04 | 3.00 | 2.00 | 0.01 |
| Sarcopenic | 9 | 28 | 0.04 | 4 | 22 | 0.01 |
Continuous parameters are reported as median, and categorical parameters are counted. DPP: Diameterof Pancreatic Parenchyma, DPD: Diameter of Pancreatic Duct; AVAT: Area of visceral adipose tissue; AMPSO: Area of psoas muscle; AMSPI: Area of dorsospinal muscles; AMVEN: Area of ventral abdominal muscles, AMTOT: total muscle area. p: level of significance was determined by the Mann-Whitney-U Test. bold numbers indicate p < 0.05